Buy or Sell: Starbucks (SBUX) and Luckin Coffee (LKNCY)

NASDAQ: SBUX | Starbucks Corp. News, Ratings, and Charts

SBUX – Despite the macroeconomic challenges, the restaurant industry looks poised for stable growth. However, is this the right time to invest in Starbucks (SBUX) and Luckin Coffee (LKNCY)? Continue reading to find out…

While the restaurant industry is grappling with inflation, labor shortage, supply chain disruptions, and rising interest rates, operators remain optimistic. So, investors looking for quality restaurant stocks can consider buying Starbucks Corporation (SBUX) and Luckin Coffee Inc. (LKNCY).

Six in 10 operators expect higher sales in the coming months. Also, as per the National Restaurant Association’s 2023 State of the Restaurant Industry report from earlier this year, nearly 3 in 4 operators say business conditions are already close to normal.

According to the organization, the food service industry is forecast to reach $997 billion in sales in 2023, driven in part by higher menu prices.

In addition, the U.S. fast food & quick service restaurant (QSR) market is estimated to grow at a CAGR of 5.6% until 2030. Investors’ interest in restaurant stocks is evident from the Advisor Shares Restaurant ETF’s (EATZ) 4.8% gain over the past month.

Let’s delve deeper into the fundamentals of the featured stocks.

Starbucks Corporation (SBUX)

SBUX and its subsidiaries, operate as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America; International; and Channel Development.

On April 20, 2023, SBUX announced the official launch of a new range of coffee beverages called “Oleato” on April 20, 2023, at more than 60 select outlets across Japan, including Starbucks Reserve Roastery Tokyo. Starbucks’ new coffee line might potentially raise sales and income.

SBUX’s trailing-12-month ROTA of 12.43% is 219.3% higher than the industry average of 3.89%. Its trailing-12-month ROTC of 18.64% is 195.1% higher than the industry average of 6.32%.

SBUX’s total net revenue increased 14.2% year-over-year to $8.72 billion for the fiscal second quarter that ended April 2, 2023. Its non-GAAP operating income increased 25% from the previous-year quarter to $1.25 billion.

Its net earnings attributable to SBUX grew 34.7% year-over-year to $908.30 million, and its non-GAAP EPS increased 25.4% from the previous-year quarter to $0.74.

Analysts expect SBUX’s revenue to increase 12% year-over-year to $36.13 billion in 2023. Its EPS is expected to grow 16.1% year-over-year to $3.44 in 2023. It surpassed EPS estimates in three of four trailing quarters. SBUX’s stock has gained 40.2% over the past year to close its last trading session at $102.90.

SBUX’s POWR Ratings reflect this promising outlook. The stock has an overall rating of B, equating to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.

SBUX has a B grade for Momentum, Sentiment, Stability, and Quality. Within the A-rated Restaurants industry, it is ranked #12 out of 45 stocks. Click here for the additional POWR Ratings for Growth and Quality SBUX.

Luckin Coffee Inc. (LKNCY)

Headquartered in Xiamen, the People’s Republic of China, LKNCY offers retail services of freshly brewed drinks and pre-made food and beverage items in the People’s Republic of China.

LKNCY’s trailing-12-month levered FCF margin of 6.24x is 119.3% higher than the 2.85x industry average. Its trailing-12-month ROTC of 15.07% is 138.5% higher than the 6.32% industry average.

For the fiscal first quarter that ended March 31, 2023, LKNCY’s total net revenues increased 84.5% year-over-year to $646.04 million. The operating income rose 97.6% over the prior-year period to $98.78 million. Its non-GAAP net income and EPS came in at $89.80 million and RMB 1.92, up 522.5% and 500% year-over-year, respectively.

The stock has gained 153.9% over the past year to close its last trading session at $20.87.

LKNCY’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall rating of B, which equates to a Buy in our proprietary rating system.

It is ranked #6 in the same industry. It has an A grade for Quality and a B for Sentiment, Momentum and Growth. To see additional LKNCY’s rating for Stability, and Value, click here.

The Bear Market is NOT Over…

That is why you need to discover this timely presentation with a trading plan and top picks from 40 year investment veteran Steve Reitmeister:

REVISED: 2023 Stock Market Outlook > 


SBUX shares were trading at $101.05 per share on Tuesday morning, down $1.85 (-1.80%). Year-to-date, SBUX has gained 2.89%, versus a 9.54% rise in the benchmark S&P 500 index during the same period.

About the Author: Rashmi Kumari

Rashmi is passionate about capital markets, wealth management, and financial regulatory issues, which led her to pursue a career as an investment analyst. With a master's degree in commerce, she aspires to make complex financial matters understandable for individual investors and help them make appropriate investment decisions. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SBUXGet RatingGet RatingGet Rating
LKNCYGet RatingGet RatingGet Rating

Most Popular Stories on

Small Problem May Loom Large for Bull Market

The stock market sure seems bullish in November given the tremendous bounce from bottom. But the large cap bias of the S&P 500 (SPY) continues to hide some of the weakness found in smaller stocks. This important topic needs to be reviewed to appreciate the health and longevity of this bull run. That topic is at the center of Steve Reitmeister’s most recent commentary that includes a preview of his top 11 picks for today’s market. Read on for more…

3 Biotech Stocks Bursting With Investment Potential

The biotech industry is well-positioned for robust growth thanks to the increasing demand for effective treatments for chronic diseases and the need to serve an aging population. To capitalize on the favorable industry trends, investing in quality biotech stocks Organogenesis Holdings (ORGO), Genmab A/S (GMAB), and Incyte (INCY) could be wise. Keep reading…

These 2 Stocks May Be the Best Bargains This Holiday Season

It’s the holiday season, and we’re all looking for the best deal from our retailers. But don’t forget to check the retail bin for some bargain stocks that may have been marked down, but are now worthy of their “sale” price. The stocks of Gap and American Outdoor Brands have had a tough run this past year in a tech frenzied market, but both retailers may be ready for some holiday cheer, and one of them is already on the move.

Tap into Massive Potential With These 3 Oil & Gas Stocks

Intensified geopolitical tensions and uncertainties coupled with OPEC+ supply cuts are contributing to potential upward pressure on global oil prices. To leverage this situation, one could invest in sound energy stocks Baker Hughes (BKR), Koninklijke Vopak (VOPKY), and NGL Energy Partners (NGL) for solid returns. Read on…

How to Profit Using The Probabilistic POWR Pairs Process

An example of grabbing gains from comparative performance with a lower risk China pairs trade on BIDU/PDD.

Read More Stories

More Starbucks Corp. (SBUX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SBUX News